# CKDu Treated With Intra-arterial Infusion of Autologous SVF Cells

> **NCT05154591** · PHASE1,PHASE2 · COMPLETED · sponsor: **Samuel Vilchez, PhD** · enrollment: 18 (actual)

## Conditions studied

- Chronic Renal Failure of Unknown Cause

## Interventions

- **GENETIC:** Adipose-derived stromal vascular fraction cells

## Key facts

- **NCT ID:** NCT05154591
- **Lead sponsor:** Samuel Vilchez, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154591, "CKDu Treated With Intra-arterial Infusion of Autologous SVF Cells". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05154591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*